VCBeat Health Contact Us
Home World's First IL-17A/IL-36R Bispecific Antibody: Huaota HB0043 Subcutaneous Injection IND Accepted by CDE

World's First IL-17A/IL-36R Bispecific Antibody: Huaota HB0043 Subcutaneous Injection IND Accepted by CDE

May 18, 2026 16:21 CST Updated May 19, 10:36
Huaota

Biological New Drug Developer